Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04485221 · ClinicalTrials.gov registry record
TECPR2 Observational Study
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 5
- Enrollment target
NCT04485221 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 5 participants.
The verdict
NCT04485221 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the disease progression in patients with a TECPR2 mutation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2023-08-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04485221
The ClinicalTrials.gov registry entry for NCT04485221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04485221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04485221 about?
NCT04485221 is a clinical study titled "TECPR2 Observational Study". The purpose of this study is to learn more about the disease progression in patients with a TECPR2 mutation.
What is the current status of trial NCT04485221?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-01-20. Estimated completion is 2023-08-17.
Who is sponsoring clinical trial NCT04485221?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.